Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Monitoring of Biopsy-Proven Interstitial Polyomavirus Nephritis in Kidney and Kidney Pancreas Transplant Recipients

This study has been completed.
Sponsor:
Information provided by:
University of Cincinnati
ClinicalTrials.gov Identifier:
NCT00374283
First received: September 8, 2006
Last updated: December 20, 2007
Last verified: December 2007
  Purpose

Evaluate techniques for monitoring the course of interstitial therapy for polyomavirus nephritis in kidney and kidney pancreas transplant recipients by monitoring blood, urine, and renal transplant biopsies of patients affected by polyomavirus.


Condition
Polyomavirus

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Monitoring of Biopsy-Proven Interstitial Polyomavirus Nephritis in Kidney and Kidney Pancreas Transplant Recipients

Resource links provided by NLM:


Further study details as provided by University of Cincinnati:

Estimated Enrollment: 40
Study Start Date: June 2001
Study Completion Date: October 2007
Detailed Description:

Evaluate techniques for monitoring the course of interstitial therapy for polyomavirus nephritis in kidney and kidney pancreas transplant recipients by monitoring blood, urine, and renal transplant biopsies of patients affected by polyomavirus.

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Recipients of a kidney or kidney pancreas transplant diagnosed with biopsy proven interstitial nephritis due to polyomavirus.
  • Age 18 to 70 years.
  • Capable of providing written informed consent.

Exclusion Criteria:

  • Age less than 18 years or greater than 70 years.
  • Patient is on chronic warfarin or heparin therapy or has a disease that puts them at risk of bleeding.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00374283

Locations
United States, Ohio
The Christ Hospital
Cincinnati, Ohio, United States, 45267
University of Cincinnati
Cincinnati, Ohio, United States, 45267
Sponsors and Collaborators
University of Cincinnati
Investigators
Principal Investigator: Prabir Roy-Chaudhury, MD, PhD University of Cincinnati
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00374283     History of Changes
Other Study ID Numbers: POLYOMA
Study First Received: September 8, 2006
Last Updated: December 20, 2007
Health Authority: United States: Institutional Review Board

Keywords provided by University of Cincinnati:
Monitoring
Polyomavirus
Kidney
Pancreas
Transplant

ClinicalTrials.gov processed this record on November 20, 2014